LLY logo Eli Lilly and Company +
Eli Lilly and Company
+

Eli Lilly and Company (LLY) Business News

Track Eli Lilly and Company in real time with a live news feed covering Eli Lilly and Company stock news, official press releases, company announcements, and an archive of historical Eli Lilly and Company news. ...more

  • Calendar
    Years
    Get instant access
    Sign up for free
    Get instant access
    Sign up for free
    Month
    Jan
    Feb
    Mar
    Apr
    May
    Jun
    Jul
    Aug
    Sep
    Oct
    Nov
    Dec
    Date
    Su
    Mo
    Tu
    We
    Th
    Fr
    Sa
    Selected Filter
    No selection
1:18 PM | Wednesday | Jul 1, 2026 24/7 Wall Street

Eli Lilly Price Prediction: The Case for Double-Digit Upside

News Thumbnail
1:09 PM | Wednesday | Jul 1, 2026 Benzinga

Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China

News Thumbnail
11:50 AM | Wednesday | Jul 1, 2026 247 Wallst

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

News Thumbnail
11:50 AM | Wednesday | Jul 1, 2026 247 Wallst

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

News Thumbnail
12:02 PM | Tuesday | Jun 30, 2026 GuruFocus

Eli Lilly Hands China Sales Rights for Verzenio to Innovent

News Thumbnail
7:14 AM | Tuesday | Jun 30, 2026 GuruFocus

Eli Lilly Expands China Cancer Reach

News Thumbnail
5:06 AM | Tuesday | Jun 30, 2026 Fool - Investing News

Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow

News Thumbnail
4:02 AM | Tuesday | Jun 30, 2026 Seeking Alpha

Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder

News Thumbnail
4:02 AM | Tuesday | Jun 30, 2026 The Motley Fool

5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX

News Thumbnail
1:57 AM | Tuesday | Jun 30, 2026 Reuters

China's Innovent Biologics gains commercialization rights for Eli Lilly breast cancer drug

News Thumbnail
12:00 AM | Tuesday | Jun 30, 2026 PRNewsWire

Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China

News Thumbnail
12:11 PM | Monday | Jun 29, 2026 Zacks Investment Research

Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs

News Thumbnail
10:31 AM | Monday | Jun 29, 2026 Zacks Investment Research

Here's Why Shares of Eli Lilly Hit an All-Time High on Friday

News Thumbnail

Eli Lilly Price Prediction: The Case for Double-Digit Upside

24/7 Wall Street

1:18 PM | Wednesday | Jul 1, 2026

news photo
Loading...

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43.

Read full article redirect
1:18 PM | Wednesday | Jul 1, 2026

Eli Lilly Price Prediction: The Case for Double-Digit Upside

24/7 Wall Street

Our 24/7 Wall St. price target for Eli Lilly (NYSE:LLY | LLY Price Prediction) is $1,349.37, pointing to 12.5% upside from a recent price of $1,199.43.

Read full article arrow
News Thumbnail
1:09 PM | Wednesday | Jul 1, 2026

Innovent, Eli Lilly Partner to Commercialize Breast Cancer Drug in China

Benzinga

Innovent Biologics, Inc. and Eli Lilly and Co. (NYSE:LLY) on Tuesday entered into a distribution and promotion agreement for Eli Lilly's breast cancer therapy Verzenios (abemaciclib) in mainland China.

Read full article arrow
News Thumbnail
11:50 AM | Wednesday | Jul 1, 2026

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

247 Wallst

If you sort all the top politicians with a portfolio of above $1 million using their annual gains, who do you expect at the top? Likely Nancy Pelosi, but that's not the case. A Republican Senator named Ashley Moody has gained 310% in the past year using her portfolio. Her portfolio and her (lack of)...
New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

Read full article arrow
News Thumbnail
11:50 AM | Wednesday | Jul 1, 2026

New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

247 Wallst

If you sort all the top politicians with a portfolio of above $1 million using their annual gains, who do you expect at the top? Likely Nancy Pelosi, but that's not the case. A Republican Senator named Ashley Moody has gained 310% in the past year using her portfolio. Her portfolio and her (lack of)...
New Nancy Pelosi? Senator Ashley Moody Up 310% in One Year With These Stocks

Read full article arrow
News Thumbnail
12:02 PM | Tuesday | Jun 30, 2026

Eli Lilly Hands China Sales Rights for Verzenio to Innovent

GuruFocus

Eli Lilly (LLY, Financials) is turning to Innovent Biologics to handle sales of Verzenio in mainland China. The breast cancer drug has been available there sinc

Read full article arrow
News Thumbnail
7:14 AM | Tuesday | Jun 30, 2026

Eli Lilly Expands China Cancer Reach

GuruFocus

Eli Lilly (LLY) is expanding its China oncology reach through a new commercialization agreement with Innovent Biologics for Verzenios.Under the deal, Innovent w

Read full article arrow
News Thumbnail
5:06 AM | Tuesday | Jun 30, 2026

Ranking Wall Street's Trillion-Dollar Stocks From Most to Least Attractive, Based on Future Cash Flow

Fool - Investing News

Among Nvidia, Apple, Alphabet, Microsoft, Amazon, Taiwan Semi, SpaceX, Broadcom, Tesla, Meta, Micron, Eli Lilly, and Berkshire Hathaway, there are a handful of bargains and pretenders.

Read full article arrow
News Thumbnail
4:02 AM | Tuesday | Jun 30, 2026

Forget Weight Loss: Eli Lilly's Real Upside Is As An AI Compounder

Seeking Alpha

Eli Lilly is leveraging its exceptional cash flow to build an AI-native drug discovery and manufacturing platform, transforming its equity narrative beyond weight loss drugs. LLY's financial momentum is extraordinary, with 2026 revenue guidance of $82–85 billion and non-GAAP EPS of $35.50–37.00, driven by Mounjaro and Zepbound. I view Lilly as an emerging AI company, with proprietary data, AI compute infrastructure, and manufacturing scale creating a compounding R&D ecosystem and operational leverage.

Read full article arrow
News Thumbnail
4:02 AM | Tuesday | Jun 30, 2026

5 Reasons Eli Lilly Is a Better Stock to Buy Right Now Than SpaceX

The Motley Fool

Investors rushed to get in on SpaceX's IPO -- and benefit from the company's innovation and growth. Eli Lilly's strength in the high-growth weight loss drug market has supercharged revenue.

Read full article arrow
News Thumbnail
1:57 AM | Tuesday | Jun 30, 2026

China's Innovent Biologics gains commercialization rights for Eli Lilly breast cancer drug

Reuters

Innovent Biologics ​has entered ‌into an agreement that ​grants ​it sole commercialization ⁠rights for ​Eli Lilly's ​breast cancer drug Verzenios in ​mainland ​China, the Chinese drugmaker ‌said ⁠Tuesday.

Read full article arrow
News Thumbnail
12:00 AM | Tuesday | Jun 30, 2026

Innovent Biologics and Lilly Enter into Commercialization Agreement for Verzenios® (abemaciclib) in Mainland China

PRNewsWire

SAN FRANCISCO and SUZHOU, China, June 30, 2026 /PRNewswire/ -- Innovent Biologics, Inc. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures, and commercializes high-quality medicines for the treatment of oncology, autoimmune, cardiovascular and metabolic, ophthalmology and other major disease areas, and Eli Lilly and Company (NYSE: LLY) today jointly announced that they have entered into a distribution and promotion agreement regarding Lilly's CDK4 & 6 inhibitor Verzenios® (abemaciclib) in mainland China: Innovent will be responsible for the importation, marketing, distribution and promotion of Verzenios® (abemaciclib) in mainland China; Lilly will continue to be responsible for manufacturing, supply, and development for the product. Verzenios® (abemaciclib), developed by Lilly, is a CDK4 & 6 inhibitor that has been approved in China for multiple indications, including: (1) Early Breast Cancer: in... Read more

Read full article arrow
News Thumbnail
12:11 PM | Monday | Jun 29, 2026

Biotech Bigwigs ABBV, JNJ, BIIB & LLY Hit New 52-Week Highs

Zacks Investment Research

LLY, ABBV, BIIB and JNJ hit new 52-week highs as biotech rallies, with company-specific pipeline, approvals and deal activity adding momentum.

Read full article arrow
News Thumbnail
10:31 AM | Monday | Jun 29, 2026

Here's Why Shares of Eli Lilly Hit an All-Time High on Friday

Zacks Investment Research

LLY hit a record high after a positive EU panel opinion for Jaypirca and expanded $50/month Medicare access for Zepbound and Foundayo.

Read full article arrow
News Thumbnail